Cargando…

The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis

BACKGROUND: Tuberculous pericardial effusion is a pro-fibrotic condition that is complicated by constrictive pericarditis in 4% to 8% of cases. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is a ubiquitous tetrapeptide with anti-fibrotic properties that is low in tuberculous pericardial effusion,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mnguni, Ayanda Trevor, Engel, Mark E., Borkum, Megan S., Mayosi, Bongani M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686106/ https://www.ncbi.nlm.nih.gov/pubmed/26656271 http://dx.doi.org/10.1371/journal.pone.0143338

Ejemplares similares

Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica
por: Xiaojun, Wang, et al.
Publicado: (2016)

N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
por: Nagai, Takako, et al.
Publicado: (2014)

βklotho is essential for the anti‐endothelial mesenchymal transition effects of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline
por: Gao, Rongfen, et al.
Publicado: (2019)

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
por: Kanasaki, Megumi, et al.
Publicado: (2011)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
por: Kanasaki, Keizo, et al.
Publicado: (2014)

N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
por: Chan, Gary C. W., et al.
Publicado: (2015)

Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
por: Srivastava, Swayam Prakash, et al.
Publicado: (2016)

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects
por: Kanasaki, Keizo
Publicado: (2020)

N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Mitigates Experimental Colitis Through Inhibition of Intestinal Mucosal Inflammatory Responses via MEK-ERK Signaling
por: Shi, Yingying, et al.
Publicado: (2020)

FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway
por: Li, Jinpeng, et al.
Publicado: (2017)

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
por: Nitta, Kyoko, et al.
Publicado: (2016)

Effects of N‐acetyl‐seryl‐asparyl‐lysyl‐proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus
por: Nakagawa, Pablo, et al.
Publicado: (2017)

Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
por: Masuyer, Geoffrey, et al.
Publicado: (2015)

Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
por: Boutonnat, Jean, et al.
Publicado: (2005)

The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis
por: Wang, Wei, et al.
Publicado: (2022)

A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP
por: Danilov, Sergei M., et al.
Publicado: (2014)

Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction
por: Nakagawa, Pablo, et al.
Publicado: (2018)

AcSDKP is down-regulated in anaemia induced by Trypanosoma brucei infection in mice
por: Musaya, Janelisa, et al.
Publicado: (2017)

Influence of the interaction between Ac-SDKP and Ang II on the pathogenesis and development of silicotic fibrosis
por: Zhang, Yi, et al.
Publicado: (2018)

Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment
por: Mao, Na, et al.
Publicado: (2021)

A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis
por: Xu, Hong, et al.
Publicado: (2012)

AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway
por: Hu, Ping, et al.
Publicado: (2013)

Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
por: Zuo, Yiqin, et al.
Publicado: (2013)

N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease
por: Morland, Cecilie, et al.
Publicado: (2022)

Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer
por: Zhao, Jin, et al.
Publicado: (2021)

The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes
por: Kołodziejczyk, Karolina, et al.
Publicado: (2009)

Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
por: Conte, Enrico, et al.
Publicado: (2016)

Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow
por: Sharma, Umesh C., et al.
Publicado: (2018)

Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica by Inhibition of TLR4 and RANKL Signaling Pathways
por: Jin, Fuyu, et al.
Publicado: (2021)

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
por: Nguyen, Tu, et al.
Publicado: (2019)

Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy
por: Asaka, Ryoichi, et al.
Publicado: (2019)

N-acetyl proline-glycine-proline: implications for neurological disorders
por: Hill, Jeff W., et al.
Publicado: (2016)

Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice
por: Han, Suo, et al.
Publicado: (2023)

Insights into substrate promiscuity of human seryl-tRNA synthetase
por: Holman, Kaitlyn M., et al.
Publicado: (2017)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection
por: Payne, Gregory A., et al.
Publicado: (2017)

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
por: Wells, J. Michael, et al.
Publicado: (2019)

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020)

Efficacy of N‐acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environmental exposure chamber
por: de Blay, Frédéric, et al.
Publicado: (2022)

The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae
por: Burnham, Susan, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8lk1jbgpdrcnei52bc533lsoml